Massive study aims to unlock mysteries of rare liver disease in china

NCT ID NCT07149675

First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 22 times

Summary

This study will follow 4,000 people with primary biliary cholangitis (PBC), a chronic autoimmune liver disease, to learn more about their symptoms, treatment responses, and long-term health outcomes. Researchers want to understand why some patients do not respond well to standard therapy and how symptoms like fatigue and itching affect quality of life. The goal is to improve care and treatment strategies for PBC patients in China.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRIMARY BILIARY CHOLANGITIS (PBC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Liver Research Center, Beijing Friendship Hospital, Capital Medical University

    RECRUITING

    Beijing, Select A State Or Province, 100069, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.